latanoprost 0.005 % Ophthalmic Solution
- RxCUI
- 314072
- RxNorm name
- latanoprost 0.005 % Ophthalmic Solution
- Display name
- latanoprost 0.005 % Ophthalmic Solution
- Full name
- latanoprost 0.005 % Ophthalmic Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LATANOPROST | LATANOPROST | NuCare Pharmaceuticals,Inc. | be74d517-7f73-a74c-e053-2a95a90a3819 | 2026-03-02 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Micro Labs Limited | 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | 2026-01-21 | Warnings, Adverse reactions | 314072 |
| Latanoprost Ophthalmic Solution | LATANOPROST OPHTHALMIC SOLUTION | Lifestar Pharma LLC | 2c87e99e-33d4-4060-8876-ff05557c05eb | 2025-12-29 | Warnings, Adverse reactions | 314072 |
| LATANOPROST | LATANOPROST | Somerset Therapeutics, LLC | 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | 2025-12-22 | Warnings, Adverse reactions | 314072 |
| latanoprost | LATANOPROST | GLENMARK PHARMACEUTICALS INC | 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | 2025-12-18 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Bausch & Lomb Incorporated | 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | 2025-10-23 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | NuCare Pharmaceuticals, Inc. | 3c47a089-2c72-f58c-e063-6294a90a4cce | 2025-08-13 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Sagent Pharmaceuticals | 7474dc53-e5e5-44f2-9f56-b2cbacdc0c32 | 2025-06-26 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | A-S Medication Solutions | 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | 2025-01-09 | Warnings, Adverse reactions | 314072 |
| latanoprost | LATANOPROST | Gland Pharma Limited | 113abcc6-6e5c-4a57-ad6a-d69508ee990e | 2024-11-29 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Proficient Rx LP | bfd773ed-c461-4732-b1ba-0c240f3fdae0 | 2024-10-01 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Aurobindo Pharma Limited | 19cdfef0-b770-4758-8f59-1769e4b6119c | 2024-09-27 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Mylan Pharmaceuticals Inc. | 463ecfde-5acb-4983-969d-0c0021bfbf48 | 2024-09-15 | Warnings, Adverse reactions | 314072 |
| LATANOPROST | LATANOPROST | Rising Pharma Holdings, Inc. | e25b82a9-1b04-4b40-8472-be107a2a6731 | 2024-08-07 | Warnings, Adverse reactions | 314072 |
| IYUZEH | LATANOPROST OPHTHALMIC SOLUTION 0.005% | Thea Pharma Inc. | 192fc081-cc38-4e83-b779-9592e060b915 | 2024-07-30 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | A-S Medication Solutions | 8fb5edec-d94a-4aad-b42e-756267a3ae55 | 2024-02-27 | Warnings, Adverse reactions | 314072 |
| XALATAN | LATANOPROST | Viatris Specialty LLC | a98595b3-9f47-48e0-b18d-550a2095f264 | 2023-05-15 | Warnings, Adverse reactions | 314072 |
| Latanoprost | LATANOPROST | Sandoz Inc | 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | 2023-01-31 | Warnings, Adverse reactions | 314072 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 463ecfde-5acb-4983-969d-0c0021bfbf48 | latanoprost 0.005 % Ophthalmic Solution | SY | 21 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240915 |
| 463ecfde-5acb-4983-969d-0c0021bfbf48 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 21 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240915 |
| 463ecfde-5acb-4983-969d-0c0021bfbf48 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 21 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240915 |
| 463ecfde-5acb-4983-969d-0c0021bfbf48 | latanoprost 0.005 % Ophthalmic Solution | PSN | 21 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240915 |
| 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 19 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251023 |
| 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 19 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251023 |
| 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | latanoprost 0.005 % Ophthalmic Solution | SY | 19 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251023 |
| 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | latanoprost 0.005 % Ophthalmic Solution | PSN | 19 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251023 |
| e25b82a9-1b04-4b40-8472-be107a2a6731 | latanoprost 0.005 % Ophthalmic Solution | PSN | 14 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996 | 20240807 |
| e25b82a9-1b04-4b40-8472-be107a2a6731 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 14 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996 | 20240807 |
| e25b82a9-1b04-4b40-8472-be107a2a6731 | latanoprost 0.005 % Ophthalmic Solution | SY | 14 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996 | 20240807 |
| e25b82a9-1b04-4b40-8472-be107a2a6731 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 14 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996 | 20240807 |
| 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 11 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20250109 |
| 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | latanoprost 0.005 % Ophthalmic Solution | SY | 11 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20250109 |
| 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 11 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20250109 |
| 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | latanoprost 0.005 % Ophthalmic Solution | PSN | 11 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20250109 |
| 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 9 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230131 |
| 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | latanoprost 0.005 % Ophthalmic Solution | PSN | 9 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230131 |
| 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 9 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230131 |
| 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | latanoprost 0.005 % Ophthalmic Solution | SY | 9 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230131 |
| 192fc081-cc38-4e83-b779-9592e060b915 | latanoprost 0.005 % Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use IYUZEH safely and effectively. See full prescribing information for IYUZEH. IYUZEH (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240730 |
| 192fc081-cc38-4e83-b779-9592e060b915 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 7 | These highlights do not include all the information needed to use IYUZEH safely and effectively. See full prescribing information for IYUZEH. IYUZEH (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240730 |
| 192fc081-cc38-4e83-b779-9592e060b915 | latanoprost 0.005 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use IYUZEH safely and effectively. See full prescribing information for IYUZEH. IYUZEH (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240730 |
| 192fc081-cc38-4e83-b779-9592e060b915 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use IYUZEH safely and effectively. See full prescribing information for IYUZEH. IYUZEH (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240730 |
| 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251222 |
| 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251222 |
| 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | latanoprost 0.005 % Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251222 |
| 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | latanoprost 0.005 % Ophthalmic Solution | PSN | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251222 |
| bfd773ed-c461-4732-b1ba-0c240f3fdae0 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20241001 |
| bfd773ed-c461-4732-b1ba-0c240f3fdae0 | latanoprost 0.005 % Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20241001 |
| bfd773ed-c461-4732-b1ba-0c240f3fdae0 | latanoprost 0.005 % Ophthalmic Solution | PSN | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20241001 |
| bfd773ed-c461-4732-b1ba-0c240f3fdae0 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 6 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20241001 |
| 113abcc6-6e5c-4a57-ad6a-d69508ee990e | latanoprost 0.005 % Ophthalmic Solution | PSN | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20241129 |
| 113abcc6-6e5c-4a57-ad6a-d69508ee990e | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20241129 |
| 113abcc6-6e5c-4a57-ad6a-d69508ee990e | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20241129 |
| 113abcc6-6e5c-4a57-ad6a-d69508ee990e | latanoprost 0.005 % Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20241129 |
| 19cdfef0-b770-4758-8f59-1769e4b6119c | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240927 |
| 19cdfef0-b770-4758-8f59-1769e4b6119c | latanoprost 0.005 % Ophthalmic Solution | PSN | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240927 |
| 19cdfef0-b770-4758-8f59-1769e4b6119c | latanoprost 0.005 % Ophthalmic Solution | SY | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240927 |
| 19cdfef0-b770-4758-8f59-1769e4b6119c | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 5 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240927 |
| 78ebea72-fd01-0552-e053-2a91aa0a698b | latanoprost 0.005 % Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20220207 |
| 78ebea72-fd01-0552-e053-2a91aa0a698b | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 4 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20220207 |
| 78ebea72-fd01-0552-e053-2a91aa0a698b | latanoprost 0.005 % Ophthalmic Solution | PSN | 4 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20220207 |
| 78ebea72-fd01-0552-e053-2a91aa0a698b | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 4 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20220207 |
| 2c87e99e-33d4-4060-8876-ff05557c05eb | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251229 |
| 2c87e99e-33d4-4060-8876-ff05557c05eb | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251229 |
| 2c87e99e-33d4-4060-8876-ff05557c05eb | latanoprost 0.005 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251229 |
| 2c87e99e-33d4-4060-8876-ff05557c05eb | latanoprost 0.005 % Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251229 |
| 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | latanoprost 0.005 % Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251218 |
| 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | latanoprost 0.005 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251218 |
| 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251218 |
| 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20251218 |
| 7c3ba2a5-54c9-e76b-e053-2a91aa0a891f | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20210217 |
| 7c3ba2a5-54c9-e76b-e053-2a91aa0a891f | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20210217 |
| 7c3ba2a5-54c9-e76b-e053-2a91aa0a891f | latanoprost 0.005 % Ophthalmic Solution | SY | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20210217 |
| 7c3ba2a5-54c9-e76b-e053-2a91aa0a891f | latanoprost 0.005 % Ophthalmic Solution | PSN | 3 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996 | 20210217 |
| be74d517-7f73-a74c-e053-2a95a90a3819 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996 | 20260302 |
| be74d517-7f73-a74c-e053-2a95a90a3819 | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996 | 20260302 |
| be74d517-7f73-a74c-e053-2a95a90a3819 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996 | 20260302 |
| be74d517-7f73-a74c-e053-2a95a90a3819 | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996 | 20260302 |
| 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20260121 |
| 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20260121 |
| 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20260121 |
| 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20260121 |
| 8fb5edec-d94a-4aad-b42e-756267a3ae55 | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240227 |
| 8fb5edec-d94a-4aad-b42e-756267a3ae55 | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240227 |
| 8fb5edec-d94a-4aad-b42e-756267a3ae55 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240227 |
| 8fb5edec-d94a-4aad-b42e-756267a3ae55 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20240227 |
| a98595b3-9f47-48e0-b18d-550a2095f264 | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN . XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230515 |
| a98595b3-9f47-48e0-b18d-550a2095f264 | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN . XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230515 |
| a98595b3-9f47-48e0-b18d-550a2095f264 | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN . XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230515 |
| a98595b3-9f47-48e0-b18d-550a2095f264 | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN . XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996 | 20230515 |
| 88efde63-9a7e-5b29-e053-2a95a90ae4cb | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996. | 20210129 |
| 88efde63-9a7e-5b29-e053-2a95a90ae4cb | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996. | 20210129 |
| 88efde63-9a7e-5b29-e053-2a95a90ae4cb | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996. | 20210129 |
| 88efde63-9a7e-5b29-e053-2a95a90ae4cb | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996. | 20210129 |
| 4bb5ec0f-317c-0992-e054-00144ff8d46c | latanoprost 0.05 MG/ML Ophthalmic Solution | SCD | 2 | LATANOPROST | 20200120 |
| 4bb5ec0f-317c-0992-e054-00144ff8d46c | latanoprost 0.005 % Ophthalmic Solution | SY | 2 | LATANOPROST | 20200120 |
| 4bb5ec0f-317c-0992-e054-00144ff8d46c | latanoprost 0.005 % Ophthalmic Solution | PSN | 2 | LATANOPROST | 20200120 |
| 4bb5ec0f-317c-0992-e054-00144ff8d46c | latanoprost 125 MCG per 2.5 ML Ophthalmic Solution | SY | 2 | LATANOPROST | 20200120 |